In the last decade, artificial intelligence (AI) has revolutionised the field of drug research. Staff abilities (55 percent), data structure (52 percent), and resources were all factors in AI deployment (49 percent ). Nearly 60% of respondents said they expected to hire more people in the next two years to assist AI usage or adoption in drug development. AI in areas like as drug research and development, drug repurposing, boosting pharmaceutical productivity, and clinical trials, among others, minimises human effort and allows for the achievement of objectives in a short amount of time. On the one hand, AI techniques used in drug development bring the drug development process and the use of various models closer to medicinal chemists, while on the other hand, AI methods used in drug development bring the drug development process and the use of various models closer to mathematicians.